Literature DB >> 21244339

IL-2 production by dendritic cells promotes Foxp3(+) regulatory T-cell expansion in autoimmune-resistant NOD congenic mice.

Evridiki Sgouroudis1, Mara Kornete, Ciriaco A Piccirillo.   

Abstract

Il2 allelic variation in non-obese diabetic mice imparts marked resistance to type 1 diabetes. IL-2 is pivotal for the fitness and homeostasis of Foxp3(+) regulatory T (T(reg)) cells, and the Idd3(B6) locus augments IL-2 production by effector T cells, which in turn enhances the potency of T(reg) cell functions. Given the important role dendritic cells (DCs) play in T(reg) cell-mediated tolerance induction, we hypothesized that DCs from Idd3(B6) congenic mice contribute to increased T(reg) cell activity. Here, we observed that CD11c(+) DCs, harboring protective Idd3(B6) genes, are endowed with the capacity to secrete IL-2, enabling them to preferentially promote T(reg) cell functions in vitro and in vivo. Our results show that Il2 gene variation may imprint DCs to favor T-cell regulation of autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21244339     DOI: 10.3109/08916934.2010.536795

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  15 in total

1.  Dendritic cell expression of the signaling molecule TRAF6 is critical for gut microbiota-dependent immune tolerance.

Authors:  Daehee Han; Matthew C Walsh; Pedro J Cejas; Nicholas N Dang; Youngmi F Kim; Jihyun Kim; Laetitia Charrier-Hisamuddin; Lillian Chau; Qin Zhang; Kyle Bittinger; Frederic D Bushman; Laurence A Turka; Hao Shen; Boris Reizis; Anthony L Defranco; Gary D Wu; Yongwon Choi
Journal:  Immunity       Date:  2013-06-20       Impact factor: 31.745

Review 2.  Mechanisms of autoimmunity in the non-obese diabetic mouse: effector/regulatory cell equilibrium during peak inflammation.

Authors:  Nadir Askenasy
Journal:  Immunology       Date:  2016-02-08       Impact factor: 7.397

3.  The role of microRNA-31 and microRNA-21 as regulatory biomarkers in the activation of T lymphocytes of Egyptian lupus patients.

Authors:  Khalda Sayed Amr; Faten S Bayoumi; Fatema T Elgengehy; Sanaa O Abdallah; Hanan H Ahmed; Eman Eissa
Journal:  Rheumatol Int       Date:  2016-08-10       Impact factor: 2.631

4.  Long-Range Transcriptional Control of the Il2 Gene by an Intergenic Enhancer.

Authors:  Parul Mehra; Andrew D Wells
Journal:  Mol Cell Biol       Date:  2015-09-08       Impact factor: 4.272

5.  Functional crosstalk between dendritic cells and Foxp3(+) regulatory T cells in the maintenance of immune tolerance.

Authors:  Mara Kornete; Ciriaco A Piccirillo
Journal:  Front Immunol       Date:  2012-06-22       Impact factor: 7.561

6.  Role of cytokines in thymus- versus peripherally derived-regulatory T cell differentiation and function.

Authors:  Jérémie David Goldstein; Louis Pérol; Bruno Zaragoza; Audrey Baeyens; Gilles Marodon; Eliane Piaggio
Journal:  Front Immunol       Date:  2013-06-19       Impact factor: 7.561

7.  Cellular mechanisms of restored β-cell tolerance mediated by protective alleles of Idd3 and Idd5.

Authors:  Emma E Hamilton-Williams; Jocelyn Cheung; Daniel B Rainbow; Kara M Hunter; Linda S Wicker; Linda A Sherman
Journal:  Diabetes       Date:  2011-11-21       Impact factor: 9.461

8.  Exogenous IL-2 controls the balance in Th1, Th17, and Treg cell distribution in patients with progressive rheumatoid arthritis treated with TNF-alpha inhibitors.

Authors:  Agata Kosmaczewska; Lidia Ciszak; Jerzy Swierkot; Aleksandra Szteblich; Katarzyna Kosciow; Irena Frydecka
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

9.  Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.

Authors:  Mara Kornete; Edward S Mason; Julien Girouard; Erin I Lafferty; Salman Qureshi; Ciriaco A Piccirillo
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

10.  Dendritic cells control CD4+CD25+ Treg cell suppressor function in vitro through juxtacrine delivery of IL-2.

Authors:  Katarina Kulhankova; Todd Rouse; Mohamed E Nasr; Elizabeth H Field
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.